| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0091-6749(96)80196-5 |
| P698 | PubMed publication ID | 8977510 |
| P50 | author | Giorgio Walter Canonica | Q56380976 |
| Giorgio Ciprandi | Q88383259 | ||
| P2093 | author name string | G Passalacqua | |
| C Pronzato | |||
| M Bagnasco | |||
| V Ricca | |||
| C Bertolini | |||
| G S Mela | |||
| P Varese | |||
| J Grögen | |||
| P433 | issue | 6 Pt 1 | |
| P921 | main subject | nasal epithelial cell | Q104695786 |
| azelastine | Q419820 | ||
| P304 | page(s) | 1088-1096 | |
| P577 | publication date | 1996-12-01 | |
| P1433 | published in | The Journal of Allergy and Clinical Immunology | Q7743550 |
| P1476 | title | Topical azelastine reduces eosinophil activation and intercellular adhesion molecule-1 expression on nasal epithelial cells: an antiallergic activity | |
| P478 | volume | 98 |
| Q43804936 | A clinical pharmacokinetic study comparing two azelastine hydrochloride nasal formulations in a single-dose design |
| Q35875669 | Allergic rhinitis in children : diagnosis and management strategies |
| Q23920137 | Assessment of upper respiratory tract and ocular irritative effects of volatile chemicals in humans |
| Q34122907 | Azelastine hydrochloride, a dual-acting anti-inflammatory ophthalmic solution, for treatment of allergic conjunctivitis |
| Q33253499 | Comparative study of topical anti-allergic eye drops on human conjunctiva-derived cells: responses to histamine and IFN gamma and toxicological profiles. |
| Q47604191 | Effect of nasal antihistamine on secretory IgA in nasal lavage of rats. |
| Q37052823 | Effectiveness of twice daily azelastine nasal spray in patients with seasonal allergic rhinitis |
| Q86584417 | Effects of azelastine nasal spray on nasal and nasopharyngeal microflora |
| Q35552828 | Effects of fexofenadine and other antihistamines on components of the allergic response: adhesion molecules |
| Q44571221 | Efficacy of azelastine nasal spray in patients with an unsatisfactory response to loratadine |
| Q34550453 | Efficacy of azelastine nasal spray in seasonal allergic rhinitis patients who remain symptomatic after treatment with fexofenadine |
| Q32019400 | Efficacy of azelastine nasal spray in the treatment of vasomotor (perennial nonallergic) rhinitis |
| Q34512065 | Evaluation of the onset and duration of effect of azelastine eye drops (0.05%) versus placebo in patients with allergic conjunctivitis using an allergen challenge model |
| Q36405243 | Experimental models for the evaluation of treatment of allergic rhinitis |
| Q35552822 | H1-receptors: localization and role in airway physiology and in immune functions |
| Q44610618 | Histamine skin test reactivity following single and multiple doses of azelastine nasal sprayin patients with seasonal allergic rhinitis |
| Q34432524 | Impact of allergic rhinitis treatment on quality of life |
| Q28268548 | Impact of azelastine nasal spray on symptoms and quality of life compared with cetirizine oral tablets in patients with seasonal allergic rhinitis |
| Q56864380 | Intranasal Azelastine |
| Q28276484 | Intranasal azelastine. A review of its efficacy in the management of allergic rhinitis |
| Q33539613 | Management of allergic rhinitis with a combination antihistamine/anti-inflammatory agent |
| Q34196627 | New insights into the second generation antihistamines |
| Q87642834 | Nonallergic rhinitis |
| Q33539610 | Pros and cons of the use of antihistamines in managing allergic rhinitis |
| Q35213458 | Safety and tolerability profiles of intranasal antihistamines and intranasal corticosteroids in the treatment of allergic rhinitis |
| Q34366390 | The ACVD task force on canine atopic dermatitis (XXI): antihistamine pharmacotherapy |
| Q64107048 | The complex pathophysiology of allergic rhinitis: scientific rationale for the development of an alternative treatment option |
| Q34595167 | The effects of the nasal antihistamines olopatadine and azelastine in nasal allergen provocation |
| Q73867748 | The potential of active metabolites of antihistamines in the management of allergic disease |
| Q41899890 | Therapeutic targeting of eosinophil adhesion and accumulation in allergic conjunctivitis |
| Q34265991 | Update on nonallergic rhinitis |
| Q84122296 | Vasomotor rhinitis |
Search more.